✨
AI Summary
- FDA's Dr. Peter Marks discusses base and prime editing.
- Potential of gene editing to meet unmet medical needs.
- Discussion on clinical holds and heritable genome editing.
Guests on This Episode
PM
Peter Marks
2 podcast appearances